The ALRCaN Global webinar, “Fitness Definition in the Era of VEN Plus HMA Therapy” is scheduled for Friday, July 3, 2026, from 09:00 AM to 10:00 AM ET.

Presented by Dr. Adriano Venditti, this session will explore the evolving definition of fitness in patients receiving venetoclax (VEN) plus hypomethylating agent (HMA) therapy. Organized by the Acute Leukemia Research and Care Network (ALRCaN), the webinar is part of the network’s weekly educational series featuring lively discussions on leukemia and supportive care topics. The session is supported by Scott Howard, Stacy Cooper, Archie Bleyer, Dan Douer, and the Resonance Team.